MedPath

Iron Supplement Effect on Child Development

Not Applicable
Completed
Conditions
Neurodevelopmental Disorders
Lactation
Interventions
Dietary Supplement: Iron fortified formula milk
Registration Number
NCT02690675
Lead Sponsor
University Rovira i Virgili
Brief Summary

Objective: To evaluate the effect of Iron supplement with two different amounts (one in the higher limit and another in the lower limit of the suggested amount) according to the presence of mutations in the HFE gene in the physical, immune and neurobehavioral development in the 6 to 12 moth toddlers.

Methodology: Subjects: 340 toddlers coming from Paediatric Serves of Sant Joan Hospital. Methods: At 6 and 12 months it done clinical history, food registry, biochemist determinations: haemoglobin, iron, transferrin, ferritin, reactive C protein and immune response (IL4, IL10, IL6 IFN, IgA, IgM, IgG, IgE). Mutations in the HFE gene: C282Y, H63D, S65D and hepcidin gene. Mental, psychomotor and behavioual development (Bayley Scales of Infant Development 2on Edition: 1993). We evaluate the level of language and communication (MacArthur), regulation and sensory process (Infant Toddler Symptom Checklist), familiar and environment surroundings (Scale Health General Parental Stress Index).

Detailed Description

Design: Randomised Clinical Trial with two groups of intervention. Group A received high-iron fortified milk (1.2mg/100mL) and Group B received low-iron fortified milk (0.4mg/100mL).

Inclusion criteria: caucasian new-borns, term infants.

Exclusion criteria:

* Families that refuse enter at the follow-up.

* Low-birth weight or preterm infants.

* Anaemic infants.

* Infants with congenital defects, immunodeficiency or hypothyroidism.

* Infants with diseases that requires intensive care.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
133
Inclusion Criteria
  • Caucasian infants
  • Healthy term infants
Exclusion Criteria
  • Families that do not understand Spanish or Catalan
  • Anaemic infants at birth
  • Infants with important diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention low-iron fortified milkIron fortified formula milkThis group received a low dose of iron by formula milk (0.4mg/100mL) between 6 and 12 months of age.
Intervention high-iron fortified milkIron fortified formula milkThis group received a high dose of iron by formula milk (1.2mg/100mL) between 6 and 12 months of age.
Primary Outcome Measures
NameTimeMethod
Mental and psychomotor development with BSID (Bayley Scale of Infant Development) at 12 months.12 months
Secondary Outcome Measures
NameTimeMethod
Risk of infections at 12 months measured qualitatively from record of presence or not of various infections as bronchitis, rhinitis, otitis etc.12 months
Height at 12 months measured in centimeters12 months
Weight at 12 months measured in grams12 months
Head circumference at 12 months measured in centimeters12 months
© Copyright 2025. All Rights Reserved by MedPath